2024-12-24 02:05:41
JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus
Corporate/ 2023-07-24
JW Therapeutics Announces IND Approval f...

SHANGHAI,April 10,2023-- JW Therapeutics (HKEX: 2126),an independent and innovative biotechnology company focusing on developing,manufacturi...

Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
Corporate/ 2023-07-24
Chinese NMPA Approves Study of Telix Bra...

MELBOURNE,Australia,April 11,2023-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company)today announces the Chinese National Medical P...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release